Two Blokes

J&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?

  • click to rate
    Posted by Two Blokes Fri at 5:30 PM - Filed in Stock - 1 view
    JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvykti and Tecvayli, and its cancer pipeline.